Don’t buy into the fear around office real estate investment trusts (REITs). Truth is, this is our moment to buy strong REIT dividends. We’re going to do it with a well-diversified 11.4%-yielding closed-end fund (CEF) trading at a ridiculous bargain. Our opportunity lies in the fact that the fear around office landlords (Will the work-from-home crowd ever return? Will lease rates plummet?…
During the go-go Gordon Gekko era of the late 1980s, I worked as an analyst on a financial magazine in midtown Manhattan. The publisher once uttered a line to me that at the time seemed appalling: “Just remember, kid: Cash is more important than your mother.” Certainly, this statement grabbed my attention. I assumed it was just hyperbole from a…
Tune into the January installment of David and I talking all things stock market, investor sentiment, the likelihood of a prolonged rally or impending correction, and real estate on The David Lin Report. Key questions and topics David asked me include: Is the momentum for the S&P 500 still on the upswing or is a major correction imminent? What technical…
While the market bounced back last year, some stocks failed to keep pace with broader equities. That was the case with these two beaten-down stocks, both of which encountered company-specific issues. Near-term headwinds aside, these two have much to offer investors, especially those willing to stay the course and hold their shares for five years or more. Let’s find out…
The medical sector is expanding due to health awareness, an aging population, and technological advancements. Given the industry’s growth prospects, investors could consider buying these fundamentally sound medical stocks for solid returns in 2024. Before delving deeper into their fundamentals, let’s discuss what’s happening in the medical industry. This post originally appeared at StockNews.com.
Political risks are rising, at home and overseas. Investors are counting on the Federal Reserve to cut interest rates this year, but if wars in the Middle East or Eastern Europe get worse and disrupt supply chains, the result would be resurgent inflation and a delay in the central bank’s dovish pivot. Accordingly, during this holiday-shortened week, I sought insights…
Typically, when markets are down, stocks that generate income through dividend payouts are more sought-after by investors. That was the case during the 2022 bear market, as a record amount of money flowed into dividend-producing exchange-traded funds (ETFs). Dividend stocks cooled off in 2023 as the stock market roared back and investors piled into technology stocks and other growth names. It is…
Several of the major U.S. stock indexes are at or near their all-time highs. The stock market is soaring right now as investors look forward to possible interest rate cuts later this year. With inflation coming back down, the Federal Reserve is set to loosen monetary policy and that has caused euphoria on Wall Street. So is it too late to get…
Following the remarkable ascent of Nvidia (NASDAQ:NVDA) last year, it’s only natural for investors to consider the top tech stocks to buy for 2024. Yeah, I suppose that NVDA could again be a winner. It’s off to a great start and the underlying generative artificial intelligence sector should only blossom from here. Still, it’s risky to target just the usual suspects. While NVDA delivered…
I am excited to be getting back in the saddle at Kitco News and am inviting you to watch my inaugural interview with the new host, Jeremy Szafron. We take a close look at the previous year and where we may be going next. Here are some of the questions and topics that Jeremy and I cover: What are my…